Society for Immunotherapy of Cancer (SITC) shared a post on LinkedIn:
“How can engineered immune cell therapies overcome the unique challenges of solid tumors?
Join Denis Migliorini, MD, at the EU IO Drug Development Summit for a dive into the latest advances, emerging strategies, and future directions shaping this rapidly evolving field.”
Other articles about Immunotherapy on OncoDaily.